Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Bioceres Crop Solutions (BIOX) Gross Profit (2016 - 2026)

Bioceres Crop Solutions' Gross Profit history spans 5 years, with the latest figure at $12.7 million for Q1 2026.

  • On a quarterly basis, Gross Profit fell 29.83% to $12.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $43.9 million, a 6.76% increase, with the full-year FY2025 number at $129.9 million, down 30.38% from a year prior.
  • Gross Profit hit $12.7 million in Q1 2026 for Bioceres Crop Solutions, down from $18.1 million in the prior quarter.
  • Over the last five years, Gross Profit for BIOX hit a ceiling of $18.1 million in Q1 2025 and a floor of $5.3 million in Q2 2022.
  • Historically, Gross Profit has averaged $12.0 million across 3 years, with a median of $12.7 million in 2026.
  • Biggest five-year swings in Gross Profit: crashed 31.69% in 2022 and later dropped 29.83% in 2026.
  • Tracing BIOX's Gross Profit over 3 years: stood at $5.3 million in 2022, then skyrocketed by 241.12% to $18.1 million in 2025, then dropped by 29.83% to $12.7 million in 2026.
  • Business Quant data shows Gross Profit for BIOX at $12.7 million in Q1 2026, $18.1 million in Q1 2025, and $5.3 million in Q2 2022.